• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    2/14/24 4:00:42 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email
    SC 13G 1 ef20021529_sc13g.htm SC 13G
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    Aveanna Healthcare Holdings Inc.
    (Name of Issuer)

    Common Stock, $0.01 par value per share
    (Title of Class of Securities)

    05356F105
    (CUSIP Number)

    December 31, 2023
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Continued on following pages
    Page 1 of 9 Pages
    Exhibit Index: Page 8



    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 2 of 9 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    NUT TREE CAPITAL MANAGEMENT, LP
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    12,372,649
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    12,372,649
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    12,372,649
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    6.5%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IA, PN
     
     
     
     


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 3 of 9 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    NUT TREE CAPITAL MANAGEMENT GP, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    12,372,649
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    12,372,649
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    12,372,649
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    6.5%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO, HC
     
     
     
     


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 4 of 9 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    JARED R. NUSSBAUM
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States of America
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    12,372,649
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    12,372,649
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    12,372,649
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    6.5%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN, HC
     
     
     
     


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 5 of 9 Pages
    Item 1(a).
    Name of Issuer:

    Aveanna Healthcare Holdings Inc. (the “Issuer”)

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    400 Interstate North Parkway SE, Atlanta, GA 30339

    Item 2(a).
    Name of Person Filing

    This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

     
    i)
    Nut Tree Capital Management, LP (“Nut Tree Capital Management”);
     
    ii)
    Nut Tree Capital Management GP, LLC (“Nut Tree Capital Management GP”); and
     
    iii)
    Jared R. Nussbaum (“Mr. Nussbaum”).

    This Statement relates to Shares (as defined herein) held by Nut Tree Master Fund, LP (“Nut Tree Master Fund”). Nut Tree Capital Management serves as investment adviser to Nut Tree Master Fund. Nut Tree Capital Management GP serves as a general partner of Nut Tree Capital Management. Mr. Nussbaum serves as Chief Investment Officer and managing partner of Nut Tree Capital Management, and is the sole member of Nut Tree Capital Management GP.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of the Reporting Persons is 55 Hudson Yards, 22nd Floor, New York, NY, 10001.

    Item 2(c).
    Citizenship:

     
    i)
    Nut Tree Capital Management is a Delaware limited partnership;
     
    ii)
    Nut Tree Capital Management GP is a Delaware limited liability company; and
     
    iii)
    Mr. Nussbaum is a citizen of the United States of America.

    Item 2(d).
    Title of Class of Securities:

    Common Stock, $0.01 par value per share (the “Shares”)

    Item 2(e).
    CUSIP Number:

    05356F105

    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),Check Whether the Person Filing is a:

     
    (e)
    ☒ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
     
    (g)
    ☒ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 6 of 9 Pages
    Item 4.
    Ownership:

    Item 4(a)
    Amount Beneficially Owned:

    As of December 31, 2023, each of the Reporting Persons may be deemed the beneficial owner of 12,372,649 Shares held by Nut Tree Master Fund.

    Item 4(b)
    Percent of Class:

    As of December 31, 2023, each of the Reporting Persons may be deemed the beneficial owner of approximately 6.5% of Shares outstanding. (There were approximately 190,733,153 Shares outstanding as of November 3, 2023, according to the Issuer’s quarterly report on Form 10-Q, filed November 9, 2023.)

    Item 4(c)
    Number of Shares as to which such person has:

    (i) Sole power to vote or direct the vote:
    0
    (ii) Shared power to vote or direct the vote:
    12,372,649
    (iii) Sole power to dispose or direct the disposition of:
    0
    (iv) Shared power to dispose or direct the disposition of:
    12,372,649

    Item 5.
    Ownership of Five Percent or Less of a Class:

    This Item 5 is not applicable.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    See disclosure in Items 2 and 4 hereof. Nut Tree Master Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the Shares covered by this statement that may be deemed to be beneficially owned by the Reporting Persons.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    See disclosure in Item 2 hereof.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.

    Item 10.
    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 7 of 9 Pages
    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    NUT TREE CAPITAL MANAGEMENT, LP
         
     
    By:
    /s/ Jared R. Nussbaum
       
    Jared R. Nussbaum, Chief Investment Officer
       
    and managing partner

     
    NUT TREE CAPITAL MANAGEMENT GP, LLC
         
     
    By:
    /s/ Jared R. Nussbaum
       
    Jared R. Nussbaum, sole member

     
    JARED R. NUSSBAUM
         
     
    By:
    /s/ Jared R. Nussbaum
         
    February 14, 2024
       


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 8 of 9 Pages
    EXHIBIT INDEX

    Ex.
     
    Page No.
         
    A
    Joint Filing Agreement
    9


    CUSIP No. 05356F105
    SCHEDULE 13G
    Page 9 of 9 Pages
    EXHIBIT A

    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Aveanna Healthcare Holdings Inc., dated as of February 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

     
    NUT TREE CAPITAL MANAGEMENT, LP
         
     
    By:

    /s/ Jared R. Nussbaum
       
    Jared R. Nussbaum, Chief Investment Officer
       
    and managing partner

     
    NUT TREE CAPITAL MANAGEMENT GP, LLC
         
     
    By:

    /s/ Jared R. Nussbaum
       
    Jared R. Nussbaum, sole member

     
    JARED R. NUSSBAUM
         
     
    By:
    /s/ Jared R. Nussbaum
         
    February 14, 2024
       



    Get the next $AVAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    1/27/2023$2.00 → $1.00Neutral → Underperform
    Credit Suisse
    11/21/2022$7.00 → $3.00Outperform → Sector Perform
    RBC Capital Mkts
    11/17/2022$5.50 → $2.00Outperform → Neutral
    Credit Suisse
    7/22/2022$2.50Buy → Hold
    Jefferies
    7/5/2022Buy → Hold
    Truist
    More analyst ratings

    $AVAH
    Leadership Updates

    Live Leadership Updates

    See more
    • Aveanna Healthcare Holdings Announces Appointment of New Director

      ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

      11/4/24 7:30:02 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

      ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

      4/3/24 6:30:06 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

      ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

      12/11/23 7:30:00 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the RBC 2025 Global Healthcare Conference

      ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 11:30 a.m. Eastern Time on the same day, May 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquart

      4/29/25 7:30:32 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference

      ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. Management will host 1x1 investor meetings as well as a presentation at 3:15 p.m. Pacific Time on the same day, May 14, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthc

      4/22/25 7:30:52 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aveanna downgraded by JP Morgan

      JP Morgan downgraded Aveanna from Neutral to Underweight

      12/13/23 6:49:11 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • UBS initiated coverage on Aveanna with a new price target

      UBS initiated coverage of Aveanna with a rating of Sell and set a new price target of $1.50

      11/30/23 7:52:45 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna downgraded by Raymond James

      Raymond James downgraded Aveanna from Strong Buy to Mkt Perform

      5/12/23 7:24:50 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner J.H. Whitney Equity Partners Vii, Llc sold $102,489 worth of shares (18,204 units at $5.63) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      4/3/25 6:09:43 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner Williams Robert M Jr sold $114,424 worth of shares (20,324 units at $5.63) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      4/3/25 6:04:16 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner Vigano Paul R sold $114,424 worth of shares (20,324 units at $5.63) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      4/3/25 6:00:17 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Financials

    Live finance-specific insights

    See more
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Announces First Quarter 2025 Earnings Release Date and Conference Call

      ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752435. The replay will be available until May 15, 2025. Int

      4/17/25 6:30:46 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Outlook

      Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period Gross margin increased 15.7% to $171.7 million compared to Q4 2023 Fourth Quarter Net income was $29.2 million compared to net loss of $25.7 million for the comparable prior year period Adjusted Net income was $11.1 million, an increase of $14.3 million compared to Q4 2023 Adjusted EBITDA for Q4 2024 was $55.2 million, a 42.8% increase as compared to Q4 2023Full Year 2025 Revenue guidance between $2.10 - $2.12 billion Full Year 2025 Adjusted EBITDA guidance between $190 - $194 million ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:A

      3/13/25 6:30:16 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

      SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      2/14/24 4:00:42 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

      SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      2/14/22 6:43:51 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    SEC Filings

    See more
    • Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/9/25 3:30:09 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/9/25 7:30:14 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Aveanna Healthcare Holdings Inc.

      10-Q - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/8/25 6:30:18 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care